Myopericarditis and myositis in a patient with COVID-19: a case report.

Asad Shabbir Christian Fielder Camm Andrew Elkington Lindsey Tilling James Stirrup Antoni ChanSacha Bull

Published in: European heart journal. Case reports (2020)

We describe the first reported case of concurrent myopericarditis, and myositis associated with COVID-19. Conventional therapy with colchicine, non-steroidal anti-inflammatory drugs, and glucocorticoids improved her symptoms, and reduced biochemical markers of myocardial and skeletal muscle inflammation.

Keyphrases

anti inflammatory drugs
coronavirus disease
sars cov
skeletal muscle
interstitial lung disease
oxidative stress
insulin resistance
myasthenia gravis
case report
left ventricular
systemic sclerosis
stem cells
rheumatoid arthritis
locally advanced
physical activity
idiopathic pulmonary fibrosis
depressive symptoms